تعداد نشریات | 37 |
تعداد شمارهها | 1,000 |
تعداد مقالات | 8,514 |
تعداد مشاهده مقاله | 15,314,471 |
تعداد دریافت فایل اصل مقاله | 10,715,736 |
New pyrazolone derivatives synthesis: comparison of the catalytic effect of three typically different Brønsted acid catalysts on the reaction progression | ||
Iranian chemical communication | ||
مقاله 5، دوره 7، Issue 1, pp. 1-89, Serial No. 22، فروردین 2019، صفحه 52-62 اصل مقاله (912.09 K) | ||
نوع مقاله: Original Research Article | ||
شناسه دیجیتال (DOI): 10.30473/icc.2018.4937 | ||
نویسندگان | ||
Gholamabbas Chehardoli* 1؛ Navid Mansouri2 | ||
1Department of Medicinal Chemistry, School of Pharmacy, Hamedan University of Medical Sciences | ||
2Department of medicinal chemistry, School of Pharmacy, Hamadan University of Medical Sciences, Hamadan 6517838695, Iran. | ||
چکیده | ||
Via the one-pot condensation reaction of ethyl acetoacetate, aromatic aldehydes, 2,4-dinitrophenylhydrazine, and β-naphthol; new pyrazolone derivatives were synthesized in the presence of three Brønsted acid catalysts. These Brønsted acid catalysts are Silica sulfuric acid (SSA), tetra-n-butyl ammonium hydrogen sulfate (TBAHSO4) and [2,2′-Bipyridine]-1,1′-diium tricyanomethanide {[2,2′-BPyH][C(CN)3]2}. Each of these combinations has its own characteristics. SSA is a heterogeneous catalyst. TBAHSO4 is a phase transfer catalyst and {[2,2′-BPyH][C(CN)3]2} is an ionic liquid. We compared the obtained results of these catalysts. In most cases, the results were comparable. But, sometimes TBAHSO4 and {[2,2′-BPyH][C(CN)3]2} give the better results to the SSA in term of reaction time and yields. Even though, isolation of SSA from products was easier than the separation of two other catalysts. | ||
کلیدواژهها | ||
Pyrazolone؛ silica sulfuric acid؛ tetra-n-butyl ammonium hydrogen sulfate؛ [2؛ 2′-bipyridine]-1؛ 1′-diium tri-cyanomethanide | ||
مراجع | ||
[1] M.R. Poor Heravi, M. Amirloo, Iran. Chem. Commun., 2014, 3, 73-84.
[2] H. Veisi, A. Maleki, Y. Farokhzad, Iran. Chem. Commun., 2017, 5, 217-226.
[3] Z. Vafajoo, D. Kordestani, S. Vafajoo, Iran. Chem. Commun., 2018, 6, 293-299.
[4] J. Zhou, W.J. Huang, G.F. Jiang, Org. Lett., 2018, 20, 1158-1161.
[5] M.T. El Sayed, M.A.M.S. El-Sharief, E.S. Zarie, N.M. Morsy, A.R. Elsheakh, A. Voronkov, et al., Bioorg. Medicin. Chem. Lett., 2018, 28, 952-957.
[6] A. Jasiecka, T. Maślanka, J. Jaroszewski, Pol. J. Vet. Sci., 2014, 17, 207-214.
[7] M. Reuvers, C. Schaefer. Analgesics and anti-inflammatory drugs. Drugs During Pregnancy and Lactation (Second Edition): Elsevier; 2007, 28-56.
[8] E. Göres, J. Kossowicz, H. Schneider, Med. Monatsschr. Pharm., 2004, 27, 72-76.
[9] H. Yoshino, A. Kimura, Amyotroph. Lat. Scler., 2006, 7, 247-251.
[10] Y. Higashi, D. Jitsuiki, K. Chayama, M. Yoshizumi, Recent Adv. Cardiovasc. Drug Discov., 2006, 1, 85-93.
[11] Y. Kakiuchi, M. Oyama, M. Nakatake, Y. Okamoto, H. Kai, H. Arima, et al., Cytologia, 2010, 75, 177-183.
[12] A. Ziarati, J. Safaei-Ghomi, S. Rohani, Ultrason. Sonochem., 2013, 20, 1069-1075.
[13] W. Wang, S.X. Wang, X.Y. Qin, J.T. Li, Synth. Commun., 2005, 35, 1263-1269.
[14] A. Hasaninejad, M. Shekouhy, A. Zare, S.H. Ghattali, N. Golzar, J. Iran. Chem. Soc., 2011, 8, 411-423.
[15] M.A. Zolfigol, G. Chehardoli, S.E. Mallakpour, Synth. Commun., 2003, 33, 833-841.
[16] M.A. Zolfigol, N. Mansouri, S. Baghery, Synlett, 2016, 27, 1511-1515.
[17] S. Sajjadifar, M.A. Zolfigol, N. Javaherneshan, G. Chehardoli, Bulg. Chem. Communi., 2017, 49, 87-91.
[18] M.A. Zolfigol, S. Sajjadifar, G. Chehardoli, N. Javaherneshan, Sci. Iran., 2014, 21, 2059-2065.
[19] S. Sajjadifar, M.A. Zolfigol, G. Chehardoli, S. Miri, P. Moosavi, Int. J. ChemTech Res., 2013, 5, 422-429.
[20] G. Chehardoli, M.A. Zolfigol, S.B. Azimi, E. Alizadeh, Chin. Chem. Lett., 2011, 22, 827-830.
[21] A. Hasaninejad, M.A. Zolfigol, G. Chehardoli, M. Mokhlesi, J. Serb. Chem. Soc., 2010, 75, 307-316.
[22] A.J. Pardey, A.B. Rivas, C. Longo, T. Funaioli, G. Fachinetti, J. Coord. Chem., 2004, 57, 871-882.
| ||
آمار تعداد مشاهده مقاله: 555 تعداد دریافت فایل اصل مقاله: 392 |